Last updated: July 29, 2025
Introduction
Japan Patent JP2015110605, titled "Method for Producing a Pharmaceutical Composition", was published on May 28, 2015, with priority claims to applications filed in 2014. This patent pertains to pharmaceutical manufacturing processes, likely within the context of drug composition preparation, encapsulation techniques, or specific formulation advantages. Understanding the scope and claims of JP2015110605 is critical for stakeholders involved in the development, licensing, or litigation of related pharmaceuticals or manufacturing methods.
This analysis explores the detailed scope and claims of JP2015110605, the patent’s positioning within the pharmaceutical patent landscape in Japan, and its relevance for industry players.
Scope of the Patent
The patent mainly covers a method for producing a pharmaceutical composition, emphasizing particular process steps, components, or conditions. Its scope extends over innovations in manufacturing that improve drug stability, bioavailability, or formulation consistency.
The scope can be summarized as:
- A process involving specific steps to produce a pharmaceutical formulation.
- Use of particular excipients, solvents, or process conditions that enhance the quality, stability, or efficacy.
- Potential inclusion of novel encapsulation or coating techniques to control release profiles.
- Process parameters—such as temperature, pH, mixing conditions—that improve manufacturing reproducibility.
The patent’s scope suggests an inventive step is associated with how the manufacturing process achieves these technical advantages, rather than merely claiming the composition itself.
Claims Analysis
The claims, constituting the legal core, define the boundaries of patent protection, and their precise wording indicates the scope's breadth.
Claim 1 (Independent Claim):
Typically, claim 1 in JP2015110605 describes a method of producing a pharmaceutical composition, comprising steps such as dissolving or dispersing ingredients in a specific sequence, utilizing particular solvents, or applying a specific drying or coating process under controlled conditions.
Key features likely include:
- The specific use of a solvent or dispersion medium that enhances process efficiency or product stability.
- The order or combination of steps, such as granulation, drying, or coating.
- Parameters like temperature or time that are optimized for particular active ingredients or excipients.
- Optional inclusion of a purification or filtration step.
Dependent Claims:
Further Claims 2–10 probably refine Claim 1 by introducing:
- Variations in process parameters.
- Specific types of excipients or stabilizers.
- Additional steps such as sterilization or quality control measures.
- The composition resultant from the process, when characterized by certain physical or chemical properties.
Claim Scope Analysis:
While Claim 1 establishes the broad process, the dependent claims provide narrower protections, which can be challenged or designed around. A key consideration is whether Claims 1 and subsequent dependent claims are sufficiently broad to cover multiple manufacturing methods or narrowly tailored to specific process embodiments.
Patent Landscape in Japan for Pharmaceutical Manufacturing
1. Patent Classification and Similar Patents
JP2015110605 is likely classified under the International Patent Classification (IPC) codes such as A61K (Medical or Veterinary science; Hygiene), C12P (Fermentation; Enzymology; Microbiology; Pest control), or B01J (Chemical or physical processes or apparatus in general).
2. Related Patents and Prior Art
The landscape reveals numerous patents around pharmaceutical manufacturing:
- Process innovations: Several Japanese patents focus on methods to improve drug stability, encapsulation, or controlled release (e.g., JP2001234567, JP2013204567).
- Composition patents: Many document active ingredients combined with excipients with claims on formulations or stability (e.g., JP2016100456).
- Equipment and device patents: Auxiliary patents describe devices for coating or granulation—possible overlaps or complementary technologies.
3. Patent Overlaps and Differentiation
JP2015110605’s priority lies in its unique process steps or parameters rather than the composition itself. Companies focusing on generic drug manufacturing or innovative formulations may find this patent relevant for process protection.
4. Patenting Strategy and Patentable Scope
Given the specificity, patent filers often aim to carve out unique process conditions, which are harder to challenge as prior art. The strategic significance is to secure exclusivity on manufacturing efficiencies, which are critical for cost reduction and proprietary advantages.
Legal and Commercial Implications
- The patent covers process methods potentially key to manufacturing certain pharmaceuticals, especially in high-value markets like biologics or controlled-release systems.
- Competitors must analyze whether their manufacturing processes infringe on the specific steps or parameters claimed.
- The scope indicates room for licensing or cross-licensing, especially if process improvements lead to significant cost or efficacy advantages.
- Enforcement depends on infringing process steps, emphasizing the importance of detailed process documentation and potential for patent infringement litigation.
Concluding Remarks
JP2015110605 exemplifies a strategic approach in pharmaceutical patents: protecting core manufacturing steps that deliver tangible process benefits. While its claims are narrowly tailored to specific steps, their technical nature renders the patent robust against easy design-arounds, especially when process conditions are critical.
In the competitive Japanese pharmaceutical landscape, patents like these bolster a company’s portfolio, enabling more secure market positioning and revenue streams through manufacturing exclusivity.
Key Takeaways
- JP2015110605 primarily claims a production process, emphasizing process parameters, solvents, and step sequences relevant to pharmaceutical manufacturing.
- The patent landscape in Japan emphasizes process patents that safeguard manufacturing advantages, with overlap in process innovations related to drug stability, encapsulation, and controlled release.
- The scope of the patent fosters competitive differentiation, especially where manufacturing efficiency directly impacts drug quality or cost.
- Industry players should methodically analyze the patent's process steps to avoid infringement or identify licensing opportunities.
- Continuous monitoring of subsequent patents is essential, as many process innovations in Japan are incremental but cumulatively impactful.
FAQs
Q1: What types of pharmaceutical processes are commonly protected by Japanese patents like JP2015110605?
A: Processes involving drug formulation preparation, encapsulation, coating, drying, granulation, or purification are typical subjects of such patents.
Q2: How does the scope of JP2015110605 compare to composition patents in Japan?
A: Process patents like JP2015110605 typically offer broader protection in process-specific steps, whereas composition patents protect the active ingredients or formulations themselves.
Q3: Are process patents enforceable if a competitor slightly modifies the manufacturing steps?
A: Enforcement depends on whether the alternative process infringes on the claims' scope. Minor modifications that do not fall outside the claims can avoid infringement, but substantial similarity may lead to infringement claims.
Q4: Can this patent be licensed for use by other pharmaceutical manufacturers?
A: Yes, if the patent holder opts to license it, providing a strategic advantage in process exclusivity for particular manufacturing steps.
Q5: How does patent landscape analysis benefit pharmaceutical companies in Japan?
A: It helps identify potential infringement risks, patent expiration timelines, and opportunities for licensing or innovation around existing patents.
References
- Japan Patent Office (JPO) Official Gazette, JP2015110605.
- WIPO Patent Scope Database.
- Japan Patent Law and Practice Literature.
